AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IS NOT SUPERIOR TO INTENSIVE CONSOLIDATION CHEMOTHERAPY (ICC) FOR POSTREMISSION THERAPY IN ADULT ACUTE MYELOBLASTIC-LEUKEMIA (AML) - FINAL ANALYSIS OF THE GOELAMS STUDY

Citation
Jy. Cahn et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IS NOT SUPERIOR TO INTENSIVE CONSOLIDATION CHEMOTHERAPY (ICC) FOR POSTREMISSION THERAPY IN ADULT ACUTE MYELOBLASTIC-LEUKEMIA (AML) - FINAL ANALYSIS OF THE GOELAMS STUDY, Experimental hematology, 24(9), 1996, pp. 671-671
Citations number
NO
Categorie Soggetti
Medicine, Research & Experimental",Hematology
Journal title
ISSN journal
0301472X
Volume
24
Issue
9
Year of publication
1996
Pages
671 - 671
Database
ISI
SICI code
0301-472X(1996)24:9<671:ABT(IN>2.0.ZU;2-X